PGGM Investments decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 34.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 519,636 shares of the healthcare conglomerate’s stock after selling 273,185 shares during the quarter. PGGM Investments’ holdings in UnitedHealth Group were worth $152,763,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of UNH. Eagle Capital Management LLC increased its position in UnitedHealth Group by 0.9% during the second quarter. Eagle Capital Management LLC now owns 16,213 shares of the healthcare conglomerate’s stock worth $3,956,000 after buying an additional 147 shares during the period. Pictet Asset Management Ltd. increased its holdings in shares of UnitedHealth Group by 1.5% in the second quarter. Pictet Asset Management Ltd. now owns 952,651 shares of the healthcare conglomerate’s stock valued at $232,456,000 after purchasing an additional 14,369 shares during the period. Gladstone Institutional Advisory LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $379,000. Assetmark Inc. increased its holdings in shares of UnitedHealth Group by 219.8% in the second quarter. Assetmark Inc. now owns 91,533 shares of the healthcare conglomerate’s stock valued at $22,335,000 after purchasing an additional 62,914 shares during the period. Finally, Baker Avenue Asset Management LP increased its holdings in shares of UnitedHealth Group by 41.1% in the second quarter. Baker Avenue Asset Management LP now owns 7,542 shares of the healthcare conglomerate’s stock valued at $1,840,000 after purchasing an additional 2,198 shares during the period. Hedge funds and other institutional investors own 85.44% of the company’s stock.
UNH stock traded down $3.21 on Friday, reaching $297.53. 1,529,419 shares of the company’s stock were exchanged, compared to its average volume of 3,851,768. The stock has a fifty day moving average of $288.85 and a 200-day moving average of $255.32. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $300.99. The firm has a market cap of $273.08 billion, a PE ratio of 23.10, a P/E/G ratio of 1.37 and a beta of 0.65. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.77 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The firm had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. During the same quarter in the prior year, the company posted $3.28 earnings per share. UnitedHealth Group’s quarterly revenue was up 4.3% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Inc will post 14.98 EPS for the current fiscal year.
UNH has been the topic of a number of recent research reports. Piper Jaffray Companies boosted their target price on UnitedHealth Group from $312.00 to $325.00 and gave the company an “overweight” rating in a report on Wednesday, December 4th. Jefferies Financial Group lowered UnitedHealth Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $300.00 to $235.00 in a report on Thursday, October 10th. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $276.00 to $361.00 and gave the company an “overweight” rating in a report on Friday, December 20th. Stephens boosted their target price on UnitedHealth Group from $325.00 to $333.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Citigroup boosted their target price on UnitedHealth Group from $286.00 to $346.00 and gave the company a “buy” rating in a report on Thursday. Five equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $313.50.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares in the company, valued at $5,531,052.48. The disclosure for this sale can be found here. Corporate insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Resistance Level
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.